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Introduction
Our research develops ultrasonicallycontrolled drug delivery systems. Previous
micellar drug carriers released the drug upon
ultrasonication. We have developed a
liposomal drug carrier that is even more
effective upon insonation in reducing tumors.

Methods

Figure 1. Application of 20 kHz US to 1 of 2 bilateral
tumors on the legs of a rat: 15 min, 1 W/cm2, CW.

Doxorubicin (Dox) in stealth liposomes was
made from phosphatidyl choline, cholesterol,
and distearoyl-phospho-ethanolamine-PEG2000 with internal ammonium sulfate buffer
(pH~4.5). Liposomes were about 250 um in
diameter. Dox was loaded by the pH gradient
method [1] (Fig 2).
Four-wk-old BDIX rats were inoculated
with DHD cancer cells on each hind leg to
grow subcutaneous tumors. After 3 weeks of
growth, Dox in stealth liposomes was injected
(4.4 mg/kg) via tail vein, and US at 20 kHz
was applied for 15 minutes and 1 W/cm2 to
only one tumor, while the other tumor was an
untreated control (Fig 1). Treatment was
repeated weekly for 4 wks. The volume was
normalized by dividing by the volume on day
1. In this first study, only 6 rats were used.

Figure 3. Rat with tumors on each leg was
given Dox-liposomes weekly. Ultrasound (20
kHz, 1 W/cm2) was applied weekly for 15 min to
the right tumor only.

Fig 4. Normalized tumor volume of 6 rats.
The red squared are treated tumors, and
the blue triangles are non-treated tumors.

Results and Discussion
Figure 2. Preparation of stealth liposomes. Dox is loaded
by the pH gradient [1]. Lipid bilayer has PEG2000 chains.

Conclusions
For this colorectal model, tumor growth is very
dependent upon the application of ultrasound and
the carrier. Ultrasound combined with Dox delivered
in our stealth liposomes is much more effective in
reducing tumor growth than Dox delivered from our
micelles. More research will reveal the mechanisms
by which ultrasound and liposomes effectively
produce tumor regression.
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Figure 4 shows the data from all rats in this study. Closed squares are the tumors receiving
US, while open diamonds represents the tumors without insonation. In contrast to data from
rats receiving micellar Dox, these data show that the tumor with US quickly regressed in size
(Fig 3).
These results stand in stark contrast to our previous studies employing ultrasound with our
micellar Dox [2]. Although the micellar formulation reduced the tumor growth rate, it rarely
caused complete regression in such a high percentage of treated tumors. In the present
study, five of six tumors regressed to non-measurable size within 4 weeks. Obviously
something occurs upon insonation with Dox in our stealth liposomes that is very different than
with micellar Dox. We are currently repeating this study on a larger population of rats.
Compared to our previous studies using ultrasound and micellar Dox delivery [2], tumor
regression is quick and very obvious. A statistical comparison (paired t-test) on the
ultrasonicated vs non-treated tumor shows that the treated side has smaller tumors (p <
0.0001).
Although we are still exploring mechanisms, we hypothesize that the ultrasound enhances
the delivery of Dox to the tumors by 2 possible mechanisms. First, we think that ultrasound is
causing cavitation that breaks open the liposomes at the insonated tumor. We also postulate
that ultrasound is rendering the tumor capillaries more permeable and liposomes are
extravasating more into the insonated tumor than the non-treated control.

